|
|
|
|
A more recent version of this article appeared on May 1, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 20, 2007
Accepted on February 11, 2008
*Departments of Immunology and Cell Biology, The Scripps Research Institute, La Jolla, CA 92037;
Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, 100 Taiwan
Monitoring Editor: Paul Forscher
The RhoA GTPase plays a vital role in assembly of contractile actin-myosin filaments (stress fibers) and of associated focal adhesion complexes of adherent monolayer cells in culture. GEF-H1 is a microtubule-associated guanine nucleotide exchange factor that activates RhoA upon release from microtubules. The overexpression of GEF-H1 deficient in microtubule binding, or treatment of HeLa cells with nocodazole to induce microtubule depolymerization results in Rho-dependent actin stress fiber formation and contractile cell morphology. However, whether GEF-H1 is required and sufficient to mediate nocodazole-induced contractility remains unclear. We establish here that siRNA-mediated depletion of GEF-H1 in HeLa cells prevents nocodazole-induced cell contraction. Furthermore, the nocodazole-induced activation of RhoA and Rho-associated kinase (ROCK) that mediates phosphorylation of myosin regulatory light chain (MLC) is impaired in GEF-H1 depleted cells. Conversely, RhoA activation and contractility are rescued by reintroduction of siRNA-resistant GEF-H1. Our studies reveal a critical role for a GEF-H1/RhoA/ROCK/MLC signaling pathway in mediating nocodazole-induced cell contractility.
Present address: Center for Medical Biotechnology, Department of Molecular Cell Biology, Faculty of Biology, University of Duisburg-Essen, Universitaetsstrasse 2, 45117 Essen, Germany.
Current address: Direvo Biotech AG, Nattermannallee 1, D-50829 Köln/Cologne, Germany.
Address correspondence to:
Gary M. Bokoch (bokoch{at}scripps.edu)